Eurotherm3235Trial: Study of Therapeutic Hypothermia for Traumatic Brain Injury
Author Information
Author(s): Peter JD Andrews, Helen Louise Sinclair, Claire G Battison, Kees H Polderman, Giuseppe Citerio, Luciana Mascia, Bridget A Harris, Gordon D Murray, Nino Stocchetti, David K Menon, Haleema Shakur, Daniel De Backer
Primary Institution: University of Edinburgh
Hypothesis
Patients treated with therapeutic hypothermia (32-35°C) have reduced morbidity and mortality rates compared to those receiving standard care alone after TBI.
Conclusion
The Eurotherm3235Trial aims to determine if therapeutic hypothermia can improve outcomes for patients with traumatic brain injury.
Supporting Evidence
- Traumatic brain injury leads to 1,000,000 hospital admissions per year in the EU.
- Therapeutic hypothermia has shown promise in improving outcomes after cardiac arrest.
- Previous studies indicate that hypothermia lasting at least 48 hours may reduce mortality.
Takeaway
This study is trying to find out if cooling patients down helps them recover better after a serious head injury.
Methodology
This is a multi-centre randomised controlled trial examining the effects of hypothermia on morbidity and mortality after traumatic brain injury.
Potential Biases
Inter-centre variance in treatment effects and experience with hypothermia may introduce bias.
Limitations
The study may face challenges in recruitment and variability in treatment protocols across different centres.
Participant Demographics
Patients aged 18-65 with primary closed traumatic brain injury and raised intracranial pressure.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website